Healthcare & Life Sciences

Long Grove Pharmaceuticals

United States

About

Long Grove Pharmaceuticals, launched by Water Street in 2019, develops complex generic drug reformulations and addresses challenging manufacturing, supply chain, and regulatory pathways in niche markets. The company both develops products for its own portfolio and partners with healthcare organizations to create entities that lead development and regulatory approval on their behalf.

Explore Long Grove Pharmaceuticals's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.